Calendar of Events Mobile Version

Hiro Matsunami, Ph.D., professor, department of molecular genetics and microbiology and department of neurobiology, Duke University School of Medicine

David Mooney, Ph.D., Robert P. Pinkas Family Professor of Bioengineering, Harvard University

Barbara Imperiali, Ph.D., professor of biology and chemistry, Massachusetts Institute of Technology

Jean Philippe-Vert, Ph.D., director, MINES ParisTech—Curie Institute

Tom A. Rapoport, Ph.D., professor, department of cell biology, Harvard Medical School; investigator, Howard Hughes Medical Institute

9:00 a.m.: Marc Tessier-Lavigne, Ph.D., president, Carson Family Professor and head, Laboratory of Brain Development and Repair, The Rockefeller University, Welcome Remarks

9:10 a.m.: Andrew D. Luster, M.D., Ph.D., chief, division of rheumatology, allergy and immunology, Massachusetts General Hospital; Persis, Cyrus and Marlow B. Harrison Professor of Medicine, Harvard Medical School, What Do Chemokines Have to Do With Fc Receptors?

9:40 a.m.: Michel C. Nussenzweig, M.D., Ph.D., senior physician, The Rockefeller University Hospital, Zanvil A. Cohn and Ralph M. Steinman Professor and head, Laboratory of Molecular Immunology, The Rockefeller University; investigator, Howard Hughes Medical Institute, Antibody Responses in Humans and Mice

10:10 a.m.: Tomohiro Kurosaki, M.D., Ph.D., professor, laboratory of lymphocyte differentiation, WPI Immunology Frontier Research Center, Osaka University, Instructive Selection of Germinal Center B Cells into the Memory Compartment

10:40 a.m.: Alan A. Aderem, Ph.D., affiliate professor, department of medicine and department of immunology, University of Washington School of Medicine; president and director, Seattle Biomedical Research Institute, A Systems Approach to Dissecting Immunity

11:10 a.m.: Fubin Li, Ph.D., principal investigator, department of microbiology and immunology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, Fc of Agonistic Antibodies

11:40 a.m.: Sir Marc Feldmann, Ph.D., M.B.B.S., professor and head, Kennedy Institute of Rheumatology, University of Oxford, Beyond Anti-TNF Therapy for Rheumatoid Arthritis: Can We Get Closer to a Cure?

1:30 p.m.: Toshiyuki Takai, Ph.D., professor, Laboratory of Experimental Immunology, Tohoku University School of Medicine, Regulatory Receptors Characterizing Peripheral B-Lineage Cells in SLE

2:00 p.m.: Mikael Karlsson, Ph.D., senior researcher and associate professor, department of microbiology, tumor and cell biology, Karolinska Institutet, Reprogramming Tumor-associated Macrophages by Antibody Targeting

2:30 p.m.: Roger M. Perlmutter, M.D., Ph.D., executive vice president and president of Merck Research Laboratories, Merck & Co., Inc., Immune-mediated Control of Malignant Disease

3:00 p.m.; Robert M. Anthony, Ph.D., principal investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital; assistant professor of medicine, Harvard Medical School, Glycan Regulation of Immunoglobulins

3:45 p.m.: Tadatsugu Taniguchi, Ph.D., professor emeritus and project professor, department of molecular immunology, Institute of Industrial Science, The University of Tokyo, The Regulation of Immune Responses by Self-derived Molecules

4:15 p.m.: Falk Nimmerjahn, Ph.D., professor, department of biology, University of Erlangen-Nuremberg, Novel Humanized Mouse Models to Understand and Modulate Human IgG Activity

4:45 p.m.: Max D. Cooper, M.D., professor, department of pathology and laboratory medicine, professor, Emory Vaccine Center, investigator, Emory Center for AIDS Research, Emory University School of Medicine, Evolution of Adaptive Immunity

5:15 p.m.: Jeffrey V. Ravetch, M.D., Ph.D., Theresa and Eugene M. Lang Professor, Leonard Wagner Laboratory of Molecular Genetics and Immunology, The Rockefeller University, Closing Remarks

Lydia Finley, Ph.D., Postdoctoral Fellow, Memorial Sloan Kettering Cancer Center

Leonidas Tsiokas, Ph.D., professor, department of cell biology, John S. Gammil Endowed Chair in Polycystic Kidney Disease, Warren Medical Research Institute, University of Oklahoma Health Sciences Center

Alexandre Pouget, Ph.D., group leader, Laboratory of Cognitive Computational Neuroscience, University of Geneva

Jennifer Doudna, Ph.D., professor, department of chemistry and department of molecular and cell biology, University of California, Berkeley; investigator, Howard Hughes Medical Institute

Joseph Schlessinger, Ph.D., William H. Prusoff Professor and Chair, department of pharmacology, Yale School of Medicine

Nicolas Brunel, Ph.D., professor, department of statistics and department of neurobiology, University of Chicago

Jolanta Grembecka, Ph.D., assistant professor, department of pathology, University of Michigan

Philip A. Beachy, Ph.D., Ernest and Amelia Gallo Professor, department of biochemistry and department of developmental biology, Stanford University School of Medicine; investigator, Howard Hughes Medical Institute

Polly Fordyce, Ph.D., assistant professor of genetics and of bioengineering, Stanford University School of Medicine

Anne-Claude Gavin, Ph.D., senior scientist, European Molecular Biology Laboratory

Eva Nogales, Ph.D., professor of biochemistry, biophysics and structural biology, University of California, Berkeley; senior faculty scientist, life sciences division, Lawrence Berkeley National Laboratory; investigator, Howard Hughes Medical Institute

Andrew Fire, Ph.D., professor of pathology and genetics, Stanford University School of Medicine

Charles Yeaman, Ph.D., associate professor of anatomy and cell biology, associate professor of internal medicine, University of Iowa Carver College of Medicine

Christopher Jarzynski, Ph.D., Distinguished University Professor, department of chemistry and biochemistry, University of Maryland

Jon Lorsch, Ph.D., director, National Institute of General Medical Sciences (NIGMS), National Institutes of Health

Jean-Pierre Eckmann, Ph.D., professor, section of mathematics, University of Geneva

Robert Wechsler-Reya, Ph.D., professor, Sanford Burnham Prebys Medical Discovery Institute

Angelika Amon, Ph.D., Kathleen and Curtis Marble Professor of Cancer Research, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology; investigator, Howard Hughes Medical Institute

Jacob Janey, Ph.D., associate director, head of chemical and synthetic development automation, Bristol-Myers Squibb Company

Richard J. Youle, Ph.D., senior investigator, Biochemistry Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health

Carolyn Bertozzi, Ph.D., Anne T. and Robert M. Bass Professor of Chemistry and professor of chemical and systems biology and radiology (by courtesy), Stanford University; investigator, Howard Hughes Medical Institute